Next Article in Journal
Screening Histories and Contact with Physicians as Determinants of Cervical Cancer Risk in Montreal, Quebec
Previous Article in Journal
Hyperammonemic Encephalopathy in An Adenocarcinoma Patient Managed with Carglumic Acid
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 6
10.3747/co.21.2143
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach

by
N. Mittmann
1,2,3,4,*,
J.M. Porter
5,
J. Rangrej
5,
S.J. Seung
1,
N. Liu
5,
R. Saskin
5,
M.C. Cheung
6,
N.B. Leighl
7,
J.S. Hoch
4,8,
M. Trudeau
6,
W.K. Evans
9,
K.N. Dainty
8,
C. DeAngelis
6 and
C.C. Earle
5,6
1
Health Outcomes and PharmacoEconomics (hope) Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada
2
Department of Pharmacology, University of Toronto, Toronto, ON, Canada
3
International Centre for Health Innovation, Richard Ivey School of Business, Western University, London, ON, Canada
4
Applied Research in Cancer Control, Cancer Care Ontario, Toronto, ON, Canada
5
Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
6
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8
Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada
9
McMaster University, Hamilton, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(6), 281-293; https://doi.org/10.3747/co.21.2143
Submission received: 3 September 2014 / Revised: 9 October 2014 / Accepted: 13 November 2014 / Published: 1 December 2014

Abstract

Objective: The objective of the present analysis was to determine the publicly funded health care costs associated with the care of breast cancer (BCa) patients by disease stage. Methods: Incident cases of female invasive BCa (2005–2009) were extracted from the Ontario Cancer Registry and linked to administrative datasets from the publicly funded system. The type and use of health care services were stratified by disease stage over the first 2 years after diagnosis. Mean costs and costs by type of clinical resource used in the care of BCa patients were compared with costs for a matched control group. The attributable cost for the 2-year time horizon was determined in 2008 Canadian dollars. Results: This cohort study involved 39,655 patients with BCa and 190,520 control subjects. The average age in those groups was 61.1 and 60.9 years respectively. Most BCa patients were classified as either stage I (34.4%) or stage II (31.8%). Of the BCa cohort, 8% died within the first 2 years after diagnosis. The overall mean cost per BCa case from a public payer perspective in the first 2 years after diagnosis was $41,686. Over the 2-year time horizon, the mean cost increased by stage: I, $29,938; II, $46,893; III, $65,369; and IV, $66,627. The attributable cost of BCa was $31,732. Cost drivers were cancer clinic visits, physician billings, and hospitalizations. Conclusions: Costs of care increased by stage of BCa. Cost drivers were cancer clinic visits, physician billings, and hospitalizations. These data will assist planning and decision-making for the use of limited health care resources.
Keywords: breast cancer; costs; population-based analysis; disease stage breast cancer; costs; population-based analysis; disease stage

Share and Cite

MDPI and ACS Style

Mittmann, N.; Porter, J.M.; Rangrej, J.; Seung, S.J.; Liu, N.; Saskin, R.; Cheung, M.C.; Leighl, N.B.; Hoch, J.S.; Trudeau, M.; et al. Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach. Curr. Oncol. 2014, 21, 281-293. https://doi.org/10.3747/co.21.2143

AMA Style

Mittmann N, Porter JM, Rangrej J, Seung SJ, Liu N, Saskin R, Cheung MC, Leighl NB, Hoch JS, Trudeau M, et al. Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach. Current Oncology. 2014; 21(6):281-293. https://doi.org/10.3747/co.21.2143

Chicago/Turabian Style

Mittmann, N., J.M. Porter, J. Rangrej, S.J. Seung, N. Liu, R. Saskin, M.C. Cheung, N.B. Leighl, J.S. Hoch, M. Trudeau, and et al. 2014. "Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach" Current Oncology 21, no. 6: 281-293. https://doi.org/10.3747/co.21.2143

APA Style

Mittmann, N., Porter, J. M., Rangrej, J., Seung, S. J., Liu, N., Saskin, R., Cheung, M. C., Leighl, N. B., Hoch, J. S., Trudeau, M., Evans, W. K., Dainty, K. N., DeAngelis, C., & Earle, C. C. (2014). Health System Costs for Stage-Specific Breast Cancer: A Population-Based Approach. Current Oncology, 21(6), 281-293. https://doi.org/10.3747/co.21.2143

Article Metrics

Back to TopTop